StockNow
Calendar
Log in
Global Markets

Novo Nordisk (NOVOB DC) US head says it has gained roughly 8 share point in obesity since January; 50% of the entire Wevogy franchise and 90% of the Wegovy pill US sales are now in self-pay channel

StockNow breaking-news AI analysis

Novo Nordisk gained roughly 8 share points in obesity since January, driven by strong self-pay adoption, with Mexico planned as the Wegovy pill's next market.

News detail

Executive says Mexico is the next market for the Wegovy pill.

1 stocks
NVONovo-Nordisk A/S$40.20Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

UKMTO has received a report of an incident involving a vessel transiting the Strait of Hormuz, reported at 07:30 UTC; tanker conducting an inbound transit was struck by an unknown projectile

Geopolitics

Yemeni Houthi official warns Egypt, Turkey and Pakistan will likely be targeted in the next stages

Geopolitics

US President Trump posts "Russia has unfortunately lost control of its Diesel Oil Industry due to its War with Ukraine"